Last reviewed · How we verify
NCT07152574
ROTAO 1 - Feasibility and Safety of the TAVIPILOT Tele-operated Robot During Transcatheter Aortic Valve Replacement (TAVR/TAVI)
NA trial testing TAVR using a tele-operated Robot in TAVI(Transcatheter Aortic Valve Implantation) in 10 participants. Not yet recruiting.
15 November 2025
Quick facts
| Lead sponsor | Caranx Medical |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 10 |
| Start date | 15 September 2025 |
| Primary completion | 15 November 2025 |
| Estimated completion | 15 February 2026 |
Drugs / interventions tested
- TAVR using a tele-operated Robot
Conditions studied
- TAVI(Transcatheter Aortic Valve Implantation) — all drugs for TAVI(Transcatheter Aortic Valve Implantation) →
Sponsor
Caranx Medical
Who can join
65 and older, any sex, with TAVI(Transcatheter Aortic Valve Implantation). Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The TAVIPILOT tele-operated robot by Caranx Medical is an advanced intraoperative robotic assistance system designed to enhance the precision of transcatheter aortic valve positioning during TAVR. The system integrates with standard procedural workflows and enables remote manipulation of delivery system components, allowing for controlled, stable, and reproducible movements. TAVIPILOT facilitates accurate valve alignment and deployment, reducing operator variability. The robot is compatible with approved balloon-expandable transcatheter heart valves (Sapien 3 and Ultra, Edwards Lifesciences, USA) and standard catheterization lab infrastructure.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07152574
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for TAVI(Transcatheter Aortic Valve Implantation)
Currently open trials in the same condition.
- NCT07052071 — Impact of Transcatheter Aortic Valve Implantation (TAVI) on the Gut Microbiota in Patients With Aortic Valve Stenosis · recruiting
- NCT07399392 — Radial Versus Femoral Secondary Access in Patients Undergoing TAVI · NA · recruiting
- NCT07521800 — Remote ECG Monitoring Post TAVI · NA · recruiting
- NCT06007222 — Non-antithrombotic Therapy After Transcatheter Aortic Valve Implantation Trial · Phase 4 · recruiting
Other Caranx Medical trials
Trials by the same sponsor.
- NCT07121907 — Feasibility and Safety of the Augmented Reality Guidance Software TAVIPILOT Software During Transcatheter Aortic Valve R · NA · not yet recruiting
- NCT07100340 — Feasibility and Safety of the Augmented Reality Guidance Software TAVIPILOT Software During Transcatheter Aortic Valve R · NA · not yet recruiting
- NCT07043075 — First-in-Human (FIH) Study on the Feasibility and Safety of the TaviPilot Augmented Reality Guidance Software · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07152574 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Caranx Medical
- Last refreshed: 3 September 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07152574.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing